Contineum Therapeutics, Inc.
public$CTNM View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $CTNM
No disclosed congressional trades found in $CTNM.
Insider Trades (Form 4)
SELLCEO and President
Stengone Carmine N.
$42,5545,000 shares Aug 3, 2026
SELLCEO and President
Stengone Carmine N.
$42,5255,000 shares Jul 8, 2026
SELLChief Scientific Officer
Lorrain Daniel S.
$627,91770,188 shares Jul 2, 2026
GRANTDirector
Miralles Gines Diego
19,000 shares Jun 26, 2026
GRANTDirector
Lyons-Williams Lori
19,000 shares Jun 26, 2026
GRANTDirector
Ware Olivia C
19,000 shares Jun 26, 2026
GRANTDirector
Schimmelpennink Evert B.
19,000 shares Jun 26, 2026
GRANTDirector
Ignelzi Troy A.
19,000 shares Jun 26, 2026
Key People
Stengone Carmine N
CEO and President
BoardInsider
Lorrain Daniel S
Chief Scientific Officer
Insider
Lyons-Williams Lori
Director
BoardInsider
Brady Todd R
Director
BoardInsider
Miralles Gines Diego
Director
BoardInsider
Schimmelpennink Evert B
Director
BoardInsider
Ignelzi Troy A
Director
BoardInsider
Ware Olivia C
Director
BoardInsider
Boyce Sarah
Director
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro